All In MedTech

FDA Clearance Tracker · P020007

MEDTRONIC AVE BRIDGE EXTRA SUPPORT OVER THE WIRE RENAL STENT SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Dec 18, 2002 (this decision)Source: openFDAMethods & limitations

PMA

The decision

FDA number
P020007
Device name
MEDTRONIC AVE BRIDGE EXTRA SUPPORT OVER THE WIRE RENAL STENT SYSTEM
Applicant location
Santa Rosa, CA
Received
Feb 15, 2002
Decided
Dec 18, 2002
Decision
Approval withdrawn
Expedited review
Yes, flagged as expedited in FDA's record.
Supplements
1 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code NIN

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MEDTRONIC AVE BRIDGE EXTRA SUPPORT OVER-THE-WIRE (OTW) RENAL STENT SYSTEM. THE DEVICE IS INDICATED FOR USE IN PATIENTS WITH ATHEROSCLEROTIC DISEASE OF THE RENAL ARTERIES FOLLOWING SUB-OPTIMAL OR FAILED PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY (PTRA) OF A DE NOVO LESION (<=15 MM IN LENGTH) LOCATED WITHIN 10 MM OF THE AORTORENAL BORDER AND WITH A REFERENCE VESSEL DIAMETER OF 5.0 TO 7.0 MM. SUB-OPTIMAL OR FAILED PTRA INCLUDE ANY OF THE FOLLOWING: VISIBLE EVIDENCE OF A RESIDUAL STENOSIS >=50% AFTER OPTIMAL PTRA, VISIBLE EVIDENCE OF INTIMAL DISSECTION >6 MM, OR PEAK SYSTOLIC TRANS-STENOTIC GRADIENT OF >=20 MM HG OR A MEAN OF >=10 MM HG.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NIN. The earliest in FDA's data is P890017, decided Sep 27, 1991.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Medtronic Vascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.